Previous close | 0.0500 |
Open | 0.1100 |
Bid | 0.0300 |
Ask | 0.0900 |
Strike | 40.00 |
Expiry date | 2025-01-17 |
Day's range | 0.0400 - 0.1100 |
Contract range | N/A |
Volume | |
Open interest | 10.39k |
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Wall Street pros say there's more room to grow with stock markets around record highs.
U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC). The launch comes weeks after Walgreens' brand was approved by the U.S. Food and Drug Administration in April. Opioid abuse has plagued the United States for more than two decades and killed more than half a million Americans, with fentanyl and synthetic versions being a major culprit in recent years, according to government data.